A 40-year-old Miami man, Terrell Jermaine Williams, pleaded guilty in federal court Wednesday to charges involving a long-running scheme to smuggle synthetic stimulants from China into South Florida.

The agency changed its benchmarks after a trial on a Sydnexis therapy met every one.

Scientists want to redesign psychedelics so that they don’t induce a trip—but they still improve mental health.

BETHLEHEM — The drug-fueled binge of three Bethlehem men began early Friday when they snorted a synthetic drug known as flakka, police say, and ended several days later with the bludgeoned, lifeless ...

CINCINNATI (WKRC) - A potent new synthetic opioid is showing up in the Tri-State drug supply, alarming local addiction-response leaders who say the biggest danger is that users often do not know what ...

Washington, D.C. – The White House Office of National Drug Control Policy (ONDCP) has released a new video on Facebook and Instagram to raise public awareness for the grave threat that illicit drugs ...

The Food and Drug Administration (FDA) announced a new proposal Monday for flexible drug approval pathway treatments addressing ultrarare diseases. The FDA unveiled draft guidance on a proposed ...

Vanda Pharmaceuticals is riding a regulatory roller coaster over the last few months. December brought an FDA thumbs up for its new motion sickness drug Nereus. Then in January, the U.S. regulator ...

Creating a drug that might help treat or cure a health condition in humans is a long, complex process. After developing a candidate drug that shows potential—a process that, in and of itself, can take ...

Given the cost of caring for an aging population in an era of high-tech but expensive treatments, it's no wonder health-care reform occupies a lot of space in political conversations. But the devil is ...

A commentary by FDA officials Vinay Prasad, MD, MPH, and Martin Makary, MD, MPH, details the new system for drug approvals in the US. FDA Commissioner Martin Makary, MD, MPH, and his top deputy Vinay ...

HARTFORD, Conn. (WFSB) - A new Connecticut law that took effect January 1 prohibits manufacturers and wholesale distributors from increasing generic prescription drug prices beyond the annual rate of ...